Status:

COMPLETED

Protocol to Assess the Severity of Acute Kidney Injury

Lead Sponsor:

George Washington University

Conditions:

Acute Kidney Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The principal objective is to safely determine if we can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled, we will draw blood and urine for relevant...

Detailed Description

AKI is a very common disease in the intensive care unit. However, despite advances in supportive care, patients with AKI carry a high mortality rate (50% to 70%). The established AKI affects nearly 5 ...

Eligibility Criteria

Inclusion

  • 18 years and older
  • Increase in serum creatinine of 0.3 mg/dl within 48 hours or an increase of greater or equal to 150 to 200% from baseline or sustained oliguria(mean urine output of \<0.5 cc/kg/hr for 6 hours within 48 hours)
  • Written informed consent
  • Patients who already have a indwelling bladder catheter

Exclusion

  • Voluntary refusal or missing written consent of the patient or the designated legal representative
  • Patients with advanced Chronic Kidney Disease - as defined by a baseline GFR of \< 30 ml/min as calculated by the MDRD equation
  • Patients with renal transplantation
  • Pregnancy
  • Patients with an allergy or sensitivity to loop diuretics
  • Patients with a clinical syndrome consistent with pre-renal AKI
  • Defined by fractional excretion of Na of \< 1% AND no evidence of the urinary casts, or
  • Patients that are under-resuscitated as deemed by treating clinical team or
  • Patients who are actively bleeding
  • Patients with a clinical syndrome of post-renal AKI
  • Any radiological study that shows hydro-ureter, or
  • Clinical scenario wherein the obstruction is considered a likely possibility of the cause of AKI

Key Trial Info

Start Date :

April 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2013

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT00673244

Start Date

April 1 2008

End Date

December 1 2013

Last Update

October 18 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

George Washington University Hospital

Washington D.C., District of Columbia, United States, 20037